014950 — Samik Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Samik Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	8,766	12,608	31,743
Net Total Accounts Receivable
Net Total Receivables	9,628	9,109	9,490
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28,658	34,129	56,974
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25,389	24,963	27,340
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	59,032	64,309	85,223
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8,876	10,432	11,747
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	10,697	12,357	16,238
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	48,335	51,952	68,985
Total Liabilities & Shareholders' Equity	59,032	64,309	85,223
Total Common Shares Outstanding